When was OBiO Technology founded?

OBiO Technology was founded in 2013 and raised its 1st funding round 7 years after it was founded.

Where is OBiO Technology located?

OBiO Technology is headquartered in Shanghai, China.

How many employees does OBiO Technology have?

As of Mar 31, 2026, the latest employee count at OBiO Technology is 40.

Is OBiO Technology a funded company?

OBiO Technology is a funded company, having raised a total of $87.1M across 3 funding rounds to date. The company's 1st funding round was a $***** Series B round, raised on Mar 11, 2020.

When was the latest funding round of OBiO Technology?

OBiO Technology's latest funding was a $***** Series C round on Sep 23, 2020, with participation from 5 investors. Its primary sector is Biopharma Outsourcing. In China, the Biopharma Outsourcing sector has seen $50.6M in funding in 2026 to date.

Where does OBiO Technology rank among its competitors?

OBiO Technology ranks 39th amongst 364 active competitors, of which 22 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Abingdon Health, which secured $4.4M in Oct, 2025.

Who are the top competitors of OBiO Technology?

OBiO Technology's top competitors include Anthem Biosciences, Patheon and Syngene. Among them, Abingdon Health secured the most recent funding round in October, 2025.

OBiO Technology - 2026 Company Profile, Funding & Competitors

OBiO Technology is a public company based in Shanghai (China), founded in 2013. It operates as a Provider of viral based gene therapy CRO services. OBiO Technology has raised $87.1M in funding from investors like Loayal Valley Capital, Efung Capital and SIG. The company has 364 active competitors, including 22 funded and 99 that have exited. Its top competitors include companies like Anthem Biosciences, Patheon and Syngene.

Company Details

OBiO Technology is a provider of viral-based therapeutics through contract manufacturing services. The company offers its services to research, gene therapy drug incubation, and preparation of clinical-grade recombinant virus.

Website: www.obiosh.com
Email ID: *****@obiosh.com
Phone Number: +86 **********

Key Metrics

Founded Year

2013

Location

Shanghai, China

Stage

Public

Total Funding

$87.1M in 3 rounds

Latest Funding Round

Series C, Sep 23, 2020, $*****

Investors

Loayal Valley Capital & 12 more

Ranked

39^th among 364 active competitors

Employee Count

40 as on Mar 31, 2026

Similar Companies

Anthem Biosciences & 244 more

Exit Details

Public

View OBiO Technology's full profile

OBiO Technology got listed on Mar 22, 2022.

Click here to take a look at OBiO Technology's IPO in detail

OBiO Technology has raised a total funding of $87.1M over 3 rounds. Its first funding round was on Mar 11, 2020. Its latest funding round was a Series C round on Sep 23, 2020 for $*****. 5 investors participated in its latest round. OBiO Technology has 13 institutional investors.

Here is the list of recent funding rounds of OBiO Technology:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 23, 2020	9855798	Series C	9773320	2715638	5934989	2732174
Jul 07, 2020	6377468	Series B	7988968	1745648	5820574	8895757
Mar 11, 2020	3700043	Series B	7596106	3967686	SIG & 2 more	9649732

Access funding benchmarks and valuations. Sign up today!

View details of OBiO Technology's funding rounds and investors

OBiO Technology's employee count trend

OBiO Technology has 40 employees as of Mar 26. Here is OBiO Technology's employee count trend over the years:

Employee count trend for OBiO Technology

Uncover OBiO Technology's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of OBiO Technology include Anthem Biosciences, Patheon and Syngene. Here is the list of Top 10 competitors of OBiO Technology, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Anthem Biosciences 2006, Bengaluru (India), Public	Developer of integrated contract research development and manufacturing services	$35.7M	Portsmouthtechnologiestrialsunit, True North ... & 8 others	75/100
2nd	Patheon 1974, Durham (United States), Acquired	Global CDMO providing integrated drug development, clinical trials, and manufacturing services	$141M	Frazier Healthcare Partners, Audax Group & 3 others	74/100
3rd	Syngene 1993, Bengaluru (India), Public	Provider of contract research and manufacturing services for both small molecules and biologics	$85.9M	True North, Education Growth Partners & 9 others	72/100
4th	Abingdon Health 2008, York (United Kingdom), Public	Developer of immunoassays for diagnostic purposes	$24.1M	Imperial Innovations, Mercia & 3 others	64/100
5th	Abzena 2001, Cambridge (United Kingdom), Acquired	Provider of antibody discovery, cell line development, and bio analytics services	$67.1M	Imperial Innovations, Invesco Perpetual & 11 others	62/100
6th	Grand River Aseptic Manufacturing 2010, Grand Rapids (United States), Acquired	Aseptic manufacturing CDMO providing fill-finish services for sterile injectables	$16.9M	Municipal Employees' Retirement System, Trout Creek Ventures ... & 5 others	59/100
7th	EirGenix 2012, Taipei (Taiwan), Public	Contract development and manufacturing organization for biologics	-	CDIB Capital Group, Taiwania Capital & 3 others	58/100
8th	Daewoong Pharmaceutical 1945, Seoul (South Korea), Public	Developer of therapies for treating gastrointestinal disorders	-	Business Innovation Network	57/100
9th	Kemwell Biopharma 1980, Bengaluru (India), Acquired	A biologics CDMO providing integrated development and manufacturing	$5.72M	Subhashfamilytrust & 4 others	57/100
10th	KBI Biopharma 1996, Durham (United States), Acquired	Provider of protein formulation, process & cell line development, and cGMP services	$21M	Ballast Point Ventures, NCBiotech & 1 others	56/100
39th	OBiO Technology 2013, Shanghai (China), Public	Provider of viral based gene therapy CRO services	$87.1M	Loayal Valley Capital, Spinnotec & 11 others	46/100